3D cataract surgery: Keeping the eye in focus


surgeons learning the 3D system during a procedure

This article was reviewed by Ashley R. Brissettte, MD, MSc, FRCSC

While 3D surgery has become a staple in retinal procedures, it has yet to become prevalent in anterior segment surgery. This may change as surgeons become aware of the benefits a 3D system offers. 

According to Ashley R. Brissette, MD, MSc, FRCSC,  the degree of visualization through the surgical microscope is quite good, which could prove to be beneficial for physicians as they perform challenging procedures.

Related: OCT data useful in hands of anterior segement specialties 

“I think that there are other benefits to 3D surgery that will become readily apparent over time,” said Dr. Brissette, assistant professor of ophthalmology, Weill Corneal Medicine and New York Presbyterian Hospital, New York.

A number of factors come into play in the quest for ideal intraoperative visualization when using a surgical microscope. Dr. Brissette pointed out that during cataract surgery, the microscope must be moved to obtain a better view. Some structures are always out of focus, the video and recordings can come in and out of focus because of accommodation especially by trainees, and the illumination and magnification must be optimal. 

Ergonomics are important to Dr. Brissette. The careers of many ophthalmologists are truncated by back and neck pain caused by extended periods of surgery and examinations over the years.

Related: Personalizing cataract surgery

3D technologyTechnology is currently available (NGenuity, Alcon) (Artveo 300, Zeiss) that provides 4K 3D visualization using 3D glasses. Alcon’s system uses a digital system that processes images and then displays them. 

The Zeiss system is one of integrated digital optics, featuring intraoperative optical coherence tomography for corneal surgery and will be introducing digital overlays for toric alignment in cataract surgery, Dr. Brissette  explained. 

Dr. Brissette noted that the new technology offers exciting options for ophthalmologists.

“The three unique advantages of 3D technology are visualization, ergonomics, and education,” she said. “The last has become especially important in anterior segment surgery using the 3D heads-up systems.”

Related: 3D printing in ophthalmology 

The improvements in visualization seen with 3D technology result from the increased quality of vision to the total operating space and offers high-definition resolution intraoperatively from the nasal to the lateral canthi. 

This eliminates looking into the microscope and the frequent adjustments needed to obtain clear focus; the entire field is in focus, she emphasized.

Dr. Brissette provided an example of how well 3D technology makes surgery easier. In a patient who is a high myope undergoing cataract surgery the anterior chamber is deep and using a microscope adjusting the focus is needed to see the nuclear fragments. 

Related: Improving outcomes of cataract surgery

Because of 3D technology, there is no need to adjust the focus intraoperatively to visualize the angle during microinvasive glaucoma procedures and for corneal and conjunctival procedures.


Using 3D systems, surgeons can sit back in the chair and maintain a comfortable position during longer cases and days in the operating room. 

“This feature will help to maintain career longevity,” she said.

Related: Heads-up technology brings ergonomics to cataract surgery

Education likely is one of the most important benefits of 3D systems. In complicated cases, personnel from different ophthalmic disciplines as well as residents and fellows can view the surgery simultaneously. Nurses viewing the procedures can anticipate the needs of the surgeons intraoperatively. 

No refocusing of the field of view is needed as the various surgeons move in and out of the primary position or for teaching opportunities. Surgical skills can be improved by reviewing cases in 3D with residents and fellows. 

“The educational component is becoming more and more important with the education of the next generation of ophthalmologists,” Dr. Brissette noted.

Read more by Lynda Charters

Ashley R. Brissette, MD, MSc, FRCSC
E: asb9040@med.cornell.edu
Dr. Brissette is a consultant/advisor to Alcon Laboratories, Bruder Healthcare Company, Carl Zeiss Meditec, and Eyevance Pharmaceuticals and has received grant support from Alcon Laboratories. 

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.